Language

I’m a radiation oncologist and researcher focused on clinical radiotherapy, oncology data science, molecular biomarkers, radiomics, and practical medical AI. My clinical work covers radiotherapy broadly, with a special focus on genitourinary and gastrointestinal cancers.

Notatnik Medyczny Clinical profile Publications

Employment history

Clinical, research and software profile

Broad radiotherapy practice with a genitourinary and gastrointestinal focus; radiomics and radiotherapy-data pipelines; translational biomarkers; reproducible oncology analyses; and medical AI tools for clinical documentation.

English PDFEnglish DOCXPolish PDFPolish DOCXContact

Digital health products and tools

Notatnik Medyczny

AI-assisted platform for structured clinical notes, combining pre-visit intake, OCR, dictation, and quality control. The public hackathon prototype is available as Notatnik Medyczny (ADK Prototype).

Radioonkolog.pl

Clinical profile and patient information site for radiotherapy consultations.

Research software

Open research tools for radiotherapy data pipelines, radiation-induced lymphopenia modelling, variant triage, biomarker discovery, and reproducible oncology analytics.

Clinical and translational work

From clinical practice to tools and publications
Focus areas

Education

Internships

  • 2026: Prof. Franciszek Walczak NAWA scholarship for a 6-month research stay at Dana-Farber Cancer Institute/Harvard Medical School focused on radiotherapy research in bladder cancer, including bladder-sparing strategies.
  • 2022-2023: Bekker NAWA (6 months) research fellowship in Dana-Farber Cancer Institute/Harvard Medical School/Broad Institute of MIT and Harvard, Boston, MA, USA (reference: Kent Mouw, M.D., Ph.D.)
  • 2016: ERASMUS+ research internship at the EPSRC Centre for Mathematical and Statistical Analysis of Multimodal Clinical Imaging, University of Cambridge, Cambridge, UK, focused on real-time TRUS-MRI fusion software for prostate cancer biopsy (reference: Prof. John Aston, Ph.D.)
  • 2015: IFMSA research exchange (6 weeks), Psychiatric Genetic Epidemiology & Neurobiology Laboratory (PsychGENe Lab), Upstate Medical University, Syracuse, NY, USA (reference: Stephen J. Glatt, Ph.D.)
  • 2014: neurosurgical clinical clerkship (3 weeks), University Hospital Southampton NHS Trust, Southampton, UK (reference: Paul Grundy, M.D.)
  • 2013: medical clinical clerkship (4 weeks), Mubarak Al Kabeer Hospital, Kuwait City, Kuwait (reference: Ibrahim T. Lasheen, M.D.)

Research grants, funded projects and innovation work

  • 2023 - present: ERA PerMed Consortium (Joint Transnational Call 2022), miRPOC - miRNA as biomarkers in early detection and personalised treatment in ovarian cancer, ~1 000 000 EUR [Partner PI / Polish group lead at Medical University of Lodz; consortium with Cancer Registry of Norway/Oslo University Hospital, German Cancer Research Center and Brigham and Women’s Hospital/Harvard Medical School]
  • 2023 - 2024: Radonek-AI - virtual oncology patient assistant, PLN 70,000, Student Scientific Circles Create Innovations programme, Polish Ministry of Education [PI]
  • 2019 - 2022: NCN PRELUDIUM [ID: UMO-2018/29/N/NZ5/02422], Deep artificial neural networks in the integration of the expression profile of circulating and intracellular miRNA molecules in pancreatic cancer patients. 209 860 PLN [PI]
  • 2014 - 2015: Ministry of Science and Higher Education Generation of the Future [ID: MNiSw/2014/DIR/379/GPII], PancreApp: application of the eight-dimensional Shepard approximation in the individualization of nutritional recommendations, with particular emphasis on chronic pancreatitis, PLN 37,800 [PI]
  • 2017 - 2018: Specialist in bioinformatics and medical informatics (building an internet platform to collect data for the research purposes of the project) in the project “Lodz Program for HNSCC Prevention” [ID: POWR.05.01.00-00-0011/16] co-financed by the European Union as part of the European Social Fund (European Social Fund, 1 792 260 PLN)
  • 2019-2021: Researcher in the study “Predictive Biomarkers of Radiation Toxicity (PBRTox)” [ID: POIR.04.04.00-00-2280/16] under the supervision of prof. Wojciech Fendler (Foundation for Polish Science; 1 999 651 PLN)
  • 2014-2016: Researcher in the study “Profile of circulating microRNAs in the diagnosis of rare forms of diabetes” [ID: 2012/05/E/NZ5/02130] under the supervision of prof. Wojciech Fendler (NCN SONATA BIS; 1 489 800 PLN)

Awards, honours and scholarships

  • 2025: Prof. Franciszek Walczak NAWA Programme scholarship, Polish National Agency for Academic Exchange, for a 6-month fellowship at Dana-Farber Cancer Institute / Harvard Medical School.
  • 2025: First place for final research project in the Harvard Medical School / Polish Medical Research Agency Clinical Scholars Research Training programme, for a project on rectal cancer radiochemotherapy.
  • 2022: Rector’s Award for Research Achievements in 2021, Medical University of Lodz, team award for publication series on urologic cancer (12.919 IF).
  • 2022: Best biostatistics Ph.D. thesis in 2021 (Awarded by StatSoft Polska).
  • 2022: Implementation Activity Award of Polish Ministry of Science, for work involving the implementation of diagnostic tests based on free-circulating microRNAs into clinical practice.
  • 2021: Scholarship of Polpharma Scientific Foundation for best Ph.D. students, awarded for the dissertation on deep artificial neural networks integrating circulating and intracellular miRNA profiles in pancreatic cancer.
  • 2020: Scholarship for the best Ph.D. students at the Medical University of Lodz.
  • 2019: Scholarship for the best Ph.D. students at the Medical University of Lodz.
  • 2018: Scholarship for the best Ph.D. students at the Medical University of Lodz.
  • 2017: Scholarship for the best Ph.D. students at the Medical University of Lodz.
  • 2016: Scholarship for the best Ph.D. students at the Medical University of Lodz.
  • 2016: Scholarship of the City of Lodz for the best Ph.D. students.
  • 2016: Winner of Adzuna’s Polish “Graduate of the Year” contest.
  • 2015: Scholarship of Minister of Science and Higher Education & Minister of Health of Republic of Poland for outstanding achievements for students in the academic year 2015/2016.
  • 2015: Scholarship of Marshal of the Lodzkie Region (highest degree)
  • 2014: Distinction in a nationwide competition “Studencki Nobel” (Eng. “Student’s Nobel Prize”).
  • 2014: Special Award for the Youngest Winner of the Session at the conference 10. International & 52. Polish Training & Scientific Medical Congress of Students’ Scientific Societies and Junior Doctors “Juvenes Pro Medicina” 2014 in Łódź (founder: Aldona Ochęcka-Szymańska M.D., Ph.D.)
  • 2013: Scholarship of Minister of Science and Higher Education of Republic of Poland for outstanding achievements for students in the academic year 2013/2014;

Patents and commercializations

  • WO2023283476A2, CA3223723A1, and AU2022306397A1, entitled “Circulating microRNA signatures for pancreatic cancer”; assignees include Medical University of Lodz and Dana-Farber Cancer Institute Inc.
  • EP3565903, US20200123614A1, US11214839B2, and US12385099, entitled “Circulating microRNA signatures for ovarian cancer”; assignees include Medical University of Lodz, Brigham and Women’s Hospital Inc., and Dana-Farber Cancer Institute Inc.; patent record also indexed by PublicUM

Research

Bibliometrics

H-index according to Google Scholar: 19
(citations = 1095; papers/abstracts = 97)

Citation and publication trends from Google Scholar. For formal publication review, use PubMed, ORCID, and OpenAlex as authoritative records.

97Google Scholar records
1,095Google Scholar citations
19H-index
2013-2026Publication years
Citations by year
Publication records by year

Selected recent publications and publication records

  • B Tomasik, M Jąkalski, M Bieńkowski, J Teodorczyk, BK Sobocki, … Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics Journal of Translational Medicine 2026:24 (1), 587 [citations: 1]
  • JW Webber, L Wollborn, S Mishra, S Alimena, B Testino, K Stawiski, … A lasso-based model combining miRNA and clinical variables predicts future risk of breast and ovarian cancer Scientific Reports 2026: [citations: 0]
  • K Kuna, J Burzyński, D Mikulski, B Sobocki, A Papis-Ubych, K Stawiski, … Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy Contemporary Oncology/Współczesna Onkologia 2026:29 (1) [citations: 0]
  • M Golinska, A Rycerz, M Sobczak, J Chrzanowski, K Stawiski, W Fendler Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis Frontiers in Immunology 2025:16, 1619434 [citations: 12]
  • M Pajdziński, J Burzyński, A Zięba, N Jędrzejczak, J Fijuth, K Stawiski 4474 Risk of Neutropenia With or Without Daratumumab in Bortezomib-Based First-Line Chemotherapy and Radiotherapy for Multiple Myeloma: A Pilot Study Radiotherapy and Oncology 2025:206, S919-S920 [citations: 0]
  • K Stawiski, A der Rycerz, J Burzyński, K Kasper, W Fendler 4567 Radonek-Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation Radiotherapy and Oncology 2025:206, S2417-S2418 [citations: 0]
  • MM Pietrzak, W Pietruszewska, M Barańska, A Rycerz, K Stawiski, … Assessment of the Interdependencies Between High-Speed Videoendoscopy and Simultaneously Recorded Audio Data in Various Glottal Pathologies Biomedicines 2025:13 (2), 511 [citations: 0]
  • D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microrna signatures for ovarian cancer US Patent 2025:12,385,099 [citations: 0]

Authoritative full records: PubMed, ORCID, OpenAlex, and Google Scholar.

Google Scholar publication records

  • B Tomasik, M Jąkalski, M Bieńkowski, J Teodorczyk, BK Sobocki, … Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics Journal of Translational Medicine 2026:24 (1), 587 [citations: 1]
  • JW Webber, L Wollborn, S Mishra, S Alimena, B Testino, K Stawiski, … A lasso-based model combining miRNA and clinical variables predicts future risk of breast and ovarian cancer Scientific Reports 2026: [citations: 0]
  • K Kuna, J Burzyński, D Mikulski, B Sobocki, A Papis-Ubych, K Stawiski, … Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy Contemporary Oncology/Współczesna Onkologia 2026:29 (1) [citations: 0]
  • M Golinska, A Rycerz, M Sobczak, J Chrzanowski, K Stawiski, W Fendler Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis Frontiers in Immunology 2025:16, 1619434 [citations: 12]
  • M Pajdziński, J Burzyński, A Zięba, N Jędrzejczak, J Fijuth, K Stawiski 4474 Risk of Neutropenia With or Without Daratumumab in Bortezomib-Based First-Line Chemotherapy and Radiotherapy for Multiple Myeloma: A Pilot Study Radiotherapy and Oncology 2025:206, S919-S920 [citations: 0]
  • K Stawiski, A der Rycerz, J Burzyński, K Kasper, W Fendler 4567 Radonek-Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation Radiotherapy and Oncology 2025:206, S2417-S2418 [citations: 0]
  • MM Pietrzak, W Pietruszewska, M Barańska, A Rycerz, K Stawiski, … Assessment of the Interdependencies Between High-Speed Videoendoscopy and Simultaneously Recorded Audio Data in Various Glottal Pathologies Biomedicines 2025:13 (2), 511 [citations: 0]
  • D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microrna signatures for ovarian cancer US Patent 2025:12,385,099 [citations: 0]
  • D Chowdhury, W Fendler, K Stawiski Circulating microrna signatures for pancreatic cancer US Patent App. 2025:18/577,387 [citations: 0]
  • S Kołowacik, BJ Bińkowski, K Stawiski, J Drożdż Time efficiency and safety of antazoline in the rapid cardioversion of recent onset atrial fibrillation during supraventricular arrhythmias ablation Polish Heart Journal (Kardiologia Polska) 2025:83 (2), 203-206 [citations: 0]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, N Juanpere Rodero, J Lee, … Tumor B cell infiltration in platinum-treated advanced urothelial carcinoma bioRxiv 2025:2025.02. 27.640395 [citations: 0]
  • FLF Carvalho, J Lee, N Kalavros, Y Zhou, D Michaud, I Stelter, H Siddiqui, … Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer bioRxiv 2025:2025.09. 08.674862 [citations: 0]
  • Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques Physics and Imaging in Radiation Oncology 2024:30, 100593 [citations: 12]
  • P Brady, A Yousif, N Sasamoto, AF Vitonis, W Fendler, K Stawiski, … Plasma microRNA expression in adolescents and young adults with endometriosis: the importance of hormone use Frontiers in Reproductive Health 2024:6, 1360417 [citations: 8]
  • A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P Robak Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens-pilot study Leukemia & Lymphoma 2024:65 (2), 257-264 [citations: 4]
  • Z Nowicka, K Kuna, M Łaszczych, K Stawiski, B Tomasik, W Fendler Effect of the time-of-day of radiotherapy administration on radiation-induced lymphocyte depletion in lung cancer International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e52 [citations: 3]
  • K Stawiski, RT Fortner, L Pestarino, SU Umu, R Kaaks, TB Rounge, … Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches Frontiers in oncology 2024:14, 1389066 [citations: 3]
  • Z Nowicka, K Kuna, K Stawiski, J Sołek, M Świderek, A Papis-Ubych, … Extreme acute radiation-induced toxicity in a patient with polymorphous low-grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes Head & Neck 2024:46 (2), E10-E17 [citations: 1]
  • D Mikulski, M Nowicki, I Dróżdż, E Perdas, P Strzałka, K Kościelny, … MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation Biomarker Research 2024:12 (1), 42 [citations: 1]
  • K Stawiski, M Bilski, J Nowak-Potemska, M Bilewicz, J Fijuth Radiation induced lymphopenia depends on lymph node irradiation in prostate cancer radiotherapy International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e549-e550 [citations: 1]
  • JW Webber, L Wollborn, S Mishra, AF Vitonis, DW Cramer, RT Phan, … Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass Gynecologic Oncology 2024:190, 124-130 [citations: 1]
  • M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth 1994: Predicting neutropenia dynamics after RT in first-line Bortezomib-based chemo for MM-a pilot study Radiotherapy and Oncology 2024:194, S1165-S1168 [citations: 0]
  • K Stawiski, M Pajdziński, A Zięba, M Masłowski, J Fijuth 3178: Development of a CT-only autosegmentation model for hippocampal delineation in radiation therapy. Radiotherapy and Oncology 2024:194, S3165-S3166 [citations: 0]
  • CJ Magnani, VD DAndrea, K Stawiski, I Stelter, T Hanlon, L Jia, AS Kibel, … AIRD1A knockouts in bladder cancer cell lines leads to MYC and E2F activation implicated in more aggressive tumor behavior European Urology 2024:85, S219-S220 [citations: 0]
  • F Mohammed, K Stawiski, HS Musa, SK Owolabi, S Abubakar, SO Rotimi, … Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and low expression of BAZ1B and KMT2D is associated with early detection and poor prognosis of prostate cancer in … Cancer Research 2024:84 (6_Supplement), 6432-6432 [citations: 0]
  • Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Physics and Imaging in Radiation Oncology Oncology 2024:30 [citations: 0]
  • BA Łochowska, K Stawiski, K Kuna, Z Nowicka, M Łochowski, J Fijuth Predicting overall survival in non-small cell lung cancer patients receiving concurrent radiochemotherapy and adjuvant durvalumab-a Polish real-world single-center experience Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2024:9 (3), 190-196 [citations: 0]
  • A Suleja, M Bliski, E Laukhtina, P Rajwa, K Stawiski, M Miszczyk Radioterapia stereotaktyczna (SBRT) w leczeniu pierwotnie zlokalizowanego raka nerkowokomórkowego (RCC)-przegląd systematyczny i metaanaliza Biuletyn Polskiego Towarzystwa Onkologicznego NOWOTWORY 2024:9 (Suppl. 1) [citations: 0]
  • FLF De Carvalho, J Lee, K Bi, B Titchen, K Stawiski, J Park, A Garza, … Tumor-immune interactions and cisplatin resistance in localized muscle-invasive bladder cancer Cancer Research 2024:84 (6_Supplement), 7041-7041 [citations: 0]
  • M Miszczyk, Ł Magrowski, T Krzysztofiak, R Stando, W Majewski, … Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group … Radiotherapy and Oncology 2023:183, 109632 [citations: 29]
  • Y Zhou, J Börcsök, E Adib, SC Kamran, AJ Neil, K Stawiski, D Freeman, … ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer Science advances 2023:9 (47), eadg2263 [citations: 25]
  • K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles Nature communications 2023:14 (1), 3350 [citations: 20]
  • Z Nowicka, B Tomasik, D Kozono, K Stawiski, T Johnson, D Haas-Kogan, … Serum miRNA-based signature indicates radiation exposure and dose in humans: a multicenter diagnostic biomarker study Radiotherapy and Oncology 2023:185, 109731 [citations: 12]
  • J Malinowski, W Pietruszewska, K Stawiski, MM Pietrzak, M Barańska, … High-speed videoendoscopy enhances the objective assessment of glottic organic lesions: a case-control study with multivariable data-mining model development Cancers 2023:15 (14), 3716 [citations: 5]
  • M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth Predicting neutropenia dynamics after radiation therapy in multiple myeloma patients receiving first-line bortezomib-based chemotherapy-a pilot study Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2023:8 (4), 274-283 [citations: 1]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, NJ Rodero, KW Mouw, … Assessing tumor-infiltrating immune cells and outcomes with cisplatin-versus carboplatin-based treatment in advanced urothelial cancer (UC): Survival analysis of three platinum … Journal of Clinical Oncology 2023:41 (16_suppl), 4583-4583 [citations: 0]
  • M Jobczyk, K Stawiski, M Kaszkowiak, P Rajwa, W Różański, F Soria, … Deep learning-based recalibration of the CUETO and EORTC prediction tools for recurrence and progression of non-muscle-invasive bladder cancer European urology oncology 2022:5 (1), 109-112 [citations: 37]
  • K Mieczkowski, K Kitowska, M Braun, B Galikowska-Bogut, … FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer Molecular Oncology 2022:16 (15), 2823-2842 [citations: 22]
  • Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski, M Ciążyńska, … The kinetics of FMS-related tyrosine kinase 3 ligand (Flt-3L) during chemoradiotherapy suggests a potential gain from the earlier initiation of immunotherapy Cancers 2022:14 (16), 3844 [citations: 17]
  • M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFbeta gene polymorphism in asthma: TGF-related SNP analysis enhances the prediction of disease diagnosis (a case-control study with multivariable data-mining model … Frontiers in immunology 2022:13, 746360 [citations: 14]
  • K Stawiski, M Kaszkowiak, D Mikulski, P Hogendorf, A Durczyński, … OmicSelector: automatic feature selection and deep learning modeling for omic experiments BioRxiv 2022:2022.06. 01.494299 [citations: 12]
  • W Fendler, B Tomasik, K Atkins, K Stawiski, J Chałubińska-Fendler, … The clinician’s guide to radiotherapy complications Polskie Archiwum Medycyny Wewnętrznej 2022:132 (1) [citations: 10]
  • A Gockley, K Pagacz, S Fiascone, K Stawiski, N Holub, K Hasselblatt, … A translational model to improve early detection of epithelial ovarian cancers Frontiers in Oncology 2022:12, 786154 [citations: 8]
  • M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski, K Stawiski, … The prognostic value of PI-RADS score in CyberKnife ultra-hypofractionated radiotherapy for localized prostate cancer Cancers 2022:14 (7), 1613 [citations: 8]
  • EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma amino acids may improve prediction accuracy of cerebral vasospasm after aneurysmal subarachnoid haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [citations: 6]
  • S Kubik, D Jesionek-Kupnicka, K Stawiski, J Fijuth, … Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma Journal of Obstetrics and Gynaecology 2022:42 (6), 2248-2254 [citations: 5]
  • EJ Bobeff, K Stawiski, PA Stanisławska, BJ Posmyk, K Wiśniewski, M Bryl, … Validation of the elderly traumatic brain injury score: observational case control study World neurosurgery 2022:161, e464-e472 [citations: 5]
  • D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microRNA signatures for ovarian cancer US Patent 2022:11,214,839 [citations: 3]
  • K Stawiski, M Maslowski, W Maslowska, M Kordzinska, B Lochowska, … Clinical and Radiomics-Based Deep Learning Predictive Model for Early Treatment Failure after Neoadjuvant Radiochemotherapy for Rectal Cancer International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e150 [citations: 0]
  • M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFbeta gene polymorphisms in asthma Frontiers in Immunology 2022:13 [citations: 0]
  • A Napieralska, J Bochenek-Cibor, A Chyrek, M Konkol, E Pawłowska, … Improving Education in Radiation Oncology in Poland International Journal of Radiation Oncology, Biology, Physics 2022:114 (1), e4-e5 [citations: 0]
  • EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [citations: 0]
  • D Mikulski, M Nowicki, I Dróźdż, E Perdas, P Strzałka, K Kościelny, … Serum miRNA-based neural network models for predicting complications in patients receiving high-dose melphalan or BeEAM conditioning chemotherapy. Acta Haematologica Polonica 2022:53 [citations: 0]
  • M Miszczyk, J Ciepał, R Stando, O Masri, I Jabłońska, K Stawiski, … The Association between Dose Escalation and Risk of Developing Metastases in Intermediate and High-Risk Prostate Cancer Patients Treated with Radiotherapy International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e231 [citations: 0]
  • M Miszczyk, E Staniewska, I Jabłońska, A Lipka-Rajwa, K Stawiski, … Volumetric staging in radiotherapy for oropharyngeal cancers Tumori Journal 2022:108 (6), 586-591 [citations: 0]
  • P Robak, D Jarych, D Mikulski, I Dróżdż, E Węgłowska, A Kotkowska, … The prognostic value of whole-blood PSMB5, CXCR4, POMP, and RPL5 mRNA expression in patients with multiple myeloma treated with bortezomib Cancers 2021:13 (5), 951 [citations: 23]
  • B Tomasik, A Papis-Ubych, K Stawiski, J Fijuth, P Kędzierawski, … Serum microRNAs as xerostomia biomarkers in patients with oropharyngeal cancer undergoing radiation therapy International Journal of Radiation Oncology Biology* Physics 2021:111 (5), 1237-1249* [citations: 18]
  • P Michał, S Konrad, K Piotr TGF-beta gene polimorphisms as risk factors for asthma control among clinic patients Journal of Inflammation 2021:18 (1), 28 [citations: 13]
  • L Lee, B Howitt, T Cheng, M King, K Stawiski, W Fendler, D Chowdhury, … MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma Gynecologic oncology 2021:163 (3), 453-458 [citations: 9]
  • D Mikulski, I Dróżdż, E Perdas, K Stawiski, M Nowicki, M Misiewicz, … Changes in the microrna expression profile in patients undergoing autologous steam cell transplantation Blood 2021:138, 4789 [citations: 5]
  • M Miszczyk, W Majewski, K Stawiski, K Rasławski, P Rajwa, I Jabłońska, … Prognostic factors in postoperative radiotherapy for prostate cancer-tertiary center experience Radiology and Oncology 2021:55 (2), 203 [citations: 4]
  • Z Nowicka, R Bibik, R Stando, W Fendler, K Stawiski, B Tomasik A link between seasonality and radiation-related toxicity: The big time or time will tell? Radiotherapy and Oncology 2021:161, 257-258 [citations: 2]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … Correction to: A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence BMC genomics 2021:22 (1), 327-327 [citations: 1]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence (vol 19, 37 … BMC GENOMICS 2021:22 (1) [citations: 0]
  • B Małachowska, B Tomasik, K Stawiski, S Kulkarni, C Guha, … Circulating microRNAs as biomarkers of radiation exposure: a systematic review and meta-analysis International Journal of Radiation Oncology Biology* Physics 2020:106 (2), 390-402* [citations: 64]
  • M Jobczyk, K Stawiski, W Fendler, W Różański Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC … Cancer Medicine 2020:9 (11), 4014-4025 [citations: 59]
  • P Robak, I Dróżdż, D Jarych, D Mikulski, E Węgłowska, M Siemieniuk-Ryś, … The value of serum microRNA expression signature in predicting refractoriness to bortezomib-based therapy in multiple myeloma patients Cancers 2020:12 (9), 2569 [citations: 28]
  • Ł Kuncman, K Stawiski, M Masłowski, J Kucharz, J Fijuth Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer Strahlentherapie und Onkologie 2020:196 (11), 998-1005 [citations: 27]
  • M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A Zielinska, … Hormonal receptor status determines prognostic significance of FGFR2 in invasive breast carcinoma Cancers 2020:12 (9), 2713 [citations: 17]
  • Z Nowicka, B Tomasik, DE Kozono, K Stawiski, TJ Johnson, … Serum Circulating MicroRNAs as Functional Biodosimeters in Patients Undergoing Total Body Irradiation International Journal of Radiation Oncology, Biology, Physics 2020:108 (3), e536 [citations: 0]
  • Z Nowicka, K Stawiski, B Tomasik, W Fendler Extracellular miRNAs as biomarkers of head and neck cancer progression and metastasis International journal of molecular sciences 2019:20 (19), 4799 [citations: 45]
  • A Zmyslowska, A Waszczykowska, D Baranska, K Stawiski, M Borowiec, … Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome Developmental Medicine & Child Neurology 2019:61 (3), 359-365 [citations: 27]
  • EJ Bobeff, J Fortuniak, B Bryszewski, K Wiśniewski, M Bryl, K Kwiecień, … Mortality after traumatic brain injury in elderly patients: a new scoring system World neurosurgery 2019:128, e129-e147 [citations: 26]
  • M Kotlicka-Antczak, MS Karbownik, K Stawiski, A Pawełczyk, N Żurner, … Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state European Psychiatry 2019:58, 72-79 [citations: 26]
  • M Zakrzewska, R Gruszka, K Stawiski, W Fendler, J Kordacka, … Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors BMC cancer 2019:19 (1), 544 [citations: 17]
  • EJ Bobeff, BJ Posmyk, K Bobeff, J Fortuniak, K Wiśniewski, K Stawiski, … Predicting outcome and conservative treatment failure in patients with skull fracture after traumatic brain injury: a retrospective cohort study Journal of Neurological Surgery Part A: Central European Neurosurgery 2019:80 (06 … [citations: 5]
  • L Kuncman, K Stawiski, M Maslowski, J Wilczynska, J Bury, J Fijuth FT3-L Dynamics in Blood Could be Predictive of Time of Occurrence Lymphocyte Nadir in Patients Undergoing Preoperative Chemoradiotherapy for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics 2019:105 (1), E167-E168 [citations: 0]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced … BMC genomics 2018:19 (1), 37 [citations: 61]
  • K Pagacz, K Stawiski, A Szadkowska, W Mlynarski, W Fendler GlyCulator2: an update on a web application for calculation of glycemic variability indices Acta diabetologica 2018:55 (8), 877-880 [citations: 37]
  • A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized … Leukemia & Lymphoma 2018:59 (5), 1084-1094 [citations: 24]
  • K Stawiski, I Pietrzak, W Młynarski, W Fendler, A Szadkowska NIRCa: An artificial neural network-based insulin resistance calculator Pediatric Diabetes 2018:19 (2), 231-235 [citations: 15]
  • KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer elife 2017:6, e28932 [citations: 174]
  • J Trelinska, I Dachowska, D Baranska, K Stawiski, K Kotulska, W Fendler, … Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study) Pediatric blood & cancer 2017:64 (6), e26347 [citations: 37]
  • K Stawiski, J Trelińska, D Baranska, I Dachowska, K Kotulska, S Jóźwiak, … What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods Magnetic Resonance Materials in Physics, Biology and Medicine 2017:30 (4), 397-405 [citations: 9]
  • KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife eLife Sciences Publications Limited 2017:6, e28932 [citations: 6]
  • A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak A systematic review and meta-analysis of B-cell receptor signaling inhibitors in relapsed and refractory chronic lymphocytic leukemia LEUKEMIA & LYMPHOMA 2017:58, 152-153 [citations: 0]
  • A Puła, KG Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Bezpieczeństwo i efektywność kliniczna nowych inhibitorów szlaku sygnałowego receptorów limfocytów B w leczeniu nawrotowej i opornej przewlekłej białaczki limfocytowej … Acta Haematologica Polonica 2017:48 (Supl. 1) [citations: 0]
  • M Zakrzewska, W Fendler, K Stawiski, R Gruszka, K Zakrzewski, … Comparative Analysis of miRNA Expression in Pediatric Neuronal and Mixed Neuronal-Glial Tumors PEDIATRIC BLOOD & CANCER 2017:64, S318-S318 [citations: 0]
  • LJ Lee, BE Howitt, W Fendler, K Stawiski, P Bu, L Cho, D Chowdhury, … miRNA profiling in a case: Control study of African American women with uterine serous carcinoma (USC). Journal of Clinical Oncology 2017:35 (15_suppl), e17116-e17116 [citations: 0]
  • KM Elias, WF Fendler, K Stawiski, A Vitonis, RS Berkowitz, DW Cramer, … Serum MicroRNA Sequencing for Early Diagnosis of Invasive Ovarian Cancer. REPRODUCTIVE SCIENCES 2017:24, 87A-87A [citations: 0]
  • Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki Patients’ awareness of the prevention and treatment of colorectal cancer Polish Journal of Surgery 2015:87, 459-463 [citations: 16]
  • K Stawiski, A Strzałka, A Puła, K Bijakowski PancreApp: an innovative approach to computational individualization of nutritional therapy in chronic gastrointestinal disorders MEDINFO 2015:2015: eHealth-enabled Health, 325-328 [citations: 10]
  • A Strzałka, K Stawiski, A Kaczmarek, A Kuchareczko, M Polguj, M Topol Analiza zmienności morfologicznych i topograficznych w zakresie struktur nerwowych i mięśniowych jamy pachowej (axillary fossa) w kontekście ich ewentualnych implikacji klinicznych Wydawnictwo Uniwersytetu Medycznego w Gdańsku 2013: [citations: 0]
  • Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski Ciazy nska, M Gottwald, L n.d.: [citations: 4]
  • K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA pro les screening n.d.:10, 1 [citations: 0]
  • K Stawiski, Ł Kuncman, M Jobczyk, M Bilski, C Franzese, M Orzechowska, … Pre-Treatment Sacral Bone Geometry Predicts Radiation-Induced Lymphopenia in Prostate Cancer Available at SSRN n.d.:650635 [citations: 0]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, N Juanpere, J Lee, … Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinoma Molecular Oncology n.d.: [citations: 0]

See the details on PubMed: https://link.konsta.com.pl/pubmed

Book chapters

  • Konrad Stawiski, Łukasz Polak, Wojciech Fendler, Jarosław Drożdż. Evidence-based medicine w kardiologii. WIELKA INTERNA: Kardiologia część 1 - wydanie II. Medical Tribune Polska 2018.
  • Konrad Stawiski, Jacek Fijuth. Sztuczna inteligencja w onkologii. Innowacyjna Onkologia: potrzeby, możliwości, system. PZWL 2020. ISBN 978-83-200-6032-4

Teaching and invited lectures

  • 2025: “Jak sztuczna inteligencja może wpłynąć na zwiększenie możliwości realizacji radioterapii - praktyka i perspektywa?”, XI Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź, Poland. Program
  • 2025: “Radioterapia w miejscowo zaawansowanym raku odbytnicy - należy eskalować leczenie systemowe”, Konferencja 4R “Dokąd zmierza nowoczesna radioterapia - Eskalacja czy Deeskalacja?”, Poland. Program
  • 2025: “Optymalizacja radio-chemioterapii po przezcewkowej resekcji (TMT) w raku pęcherza moczowego w świetle aktualnych badań”, “MISSION POSSIBLE” - Precyzja i personalizacja w onkologii, CMEducation, Warsaw, Poland. Program
  • 2025: “Leczenie trójmodalne vs cystectomia z leczeniem okołooperacyjnym - dla kogo co jest optymalnym wyborem?” - radiotherapist perspective, Uro-Onko Expert Meeting, CMEducation, Łódź, Poland. Program
  • 2024: “Total Neoadjuvant Treatment w raku odbytnicy - czy jest już standardem? Kiedy eskalować, kiedy deeskalować intensywność leczenia?”, VIII Konferencja 4R - Radioterapeuci Radioterapeutom, Warsaw, Poland. Program
  • 2024: “Synergia leczenia celowanego i radioterapii w badaniach klinicznych”, Precyzja i personalizacja - “MISSION POSSIBLE” w onkologii, CMEducation, Warsaw, Poland. Program
  • 2024: “Pisanie prac naukowych w dobie AI”, educational lecture/materials for Young PTRO. Slides
  • 2023: “Odmienne twarze Greja - dawki biologicznie równoważne w zależności od sposobu frakcjonowania i lokalizacji anatomicznej”, conference “Radioterapia stereotaktyczna w dobie leczenia celowanego”, Warsaw, Poland. Archived program
  • 2023: “Wyniki badania klinicznego - analiza oraz ocena wartości”, postgraduate studies “Non-commercial Clinical Research - Design, Implementation and Management”, Medical University in Wrocław, Poland.
  • 2022: “Czy sztuczna inteligencja zastąpi człowieka w planowaniu leczenia promieniami?”, X Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź, Poland.
  • 2022: “Deep artificial neural networks in the integration of the expression profile of circulating and intracellular miRNA molecules in pancreatic cancer patients”, Łódź Oncology Days, Łódź, Poland.
  • 2022: “Time series analysis”, postgraduate studies “Elements of empirical research methodology in medicine and application of statistics in biomedical research”, Medical University of Łódź, Poland.
  • 2022: “Introduction to Data Mining methods and the STATISTICA Data Miner system”, postgraduate studies “Elements of empirical research methodology in medicine and application of statistics in biomedical research”, Medical University of Łódź, Poland.
  • 2021-2022: “Data in clinical trials (CRF) and database management”, postgraduate studies “Non-commercial Clinical Research - Design, Implementation and Management”, Medical University in Wrocław, Poland.
  • 2021-2022: “New Technologies in Clinical Trials. Big Data”, postgraduate studies “Non-commercial Clinical Research - Design, Implementation and Management”, Medical University in Wrocław, Poland.
  • 2021: “Zastosowanie zaawansowanych narzędzi statystycznych i sztucznej inteligencji w prognozowaniu rokowania i odpowiedzi na leczenie w raku gruczołu krokowego”, “Rak stercza - wielodyscyplinarne podejście do terapii po niepowodzeniu leczenia miejscowego i w chorobie z przerzutami”, 90C webinar. Program
  • 2021: “Testy diagnostyczne, modele predykcyjne (regresja logistyczna)”, youngPTRO scientific-biostatistical workshops, Young Division of the Polish Society of Radiation Oncology. Recording
  • 2019: “Kobiety w nauce”, Pałacowy Salon Naukowy, Akademia Młodych Uczonych PAN, Jabłonna, Poland, with Beata Małachowska. Event page
  • 2019: “Nauczanie głębokie jako technika zwiększania skuteczności biomarkerów molekularnych”, IX Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź, Poland. Archived program
  • 2018: “Data mining to discover ovarian cancer signature in the miRNA serum profile”, Elias Lab Meeting, Brigham and Women’s Hospital / Dana-Farber Cancer Institute, Boston, MA, USA.
  • 2018: “From anatomy to artificial intelligence in oncology”, local science-outreach conference, Poland.

Commercial clinical trials

  • TALAPRO-2 (B9991040 / NCT04052204): Phase III randomized study of talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer.
  • NC-6004-009 (NCT03771820): Phase Ib/II study of NC-6004, a nanoparticulate cisplatin formulation, plus pembrolizumab in advanced solid tumors.
  • KEYNOTE-867 (MK-3475-867 / NCT03924869): Phase III randomized study of pembrolizumab with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer.
  • KEYNOTE-689 (MK-3475-689 / NCT03765918): Phase III study of pembrolizumab as neoadjuvant and adjuvant treatment for resectable locally advanced head-and-neck squamous-cell carcinoma.
  • CALLA (D910SC00001 / NCT04550260): Phase III randomized study of durvalumab with chemoradiotherapy in locally advanced cervical cancer.

Research software and reproducible tools

  • rect-ril (Zenodo DOI: 10.5281/zenodo.19595346) - R/Python analysis pipeline and interactive calculator for predicting severe radiation-induced lymphopenia in rectal cancer.

  • Notatnik Medyczny (ADK Prototype) - public hackathon prototype demonstrating selected AI-assisted medical-documentation functions for Notatnik Medyczny.

  • RTpipeline - research-grade pipeline transforming raw DICOM radiotherapy exports into analysis-ready data for radiotherapy, radiomics, dose-volume histogram (DVH), and machine-learning workflows (documentation).

  • Somatic Likelihood Tiering - interpretable multi-evidence framework for tumor-only whole-exome sequencing variant triage. Zenodo DOI: 10.5281/zenodo.19572621

  • Prostate AS-counselling calculators - open-access active-surveillance counselling calculator estimating biopsy-to-prostatectomy ISUP-upgrade risk (Jobczyk et al. 2026).

  • OmicSelector - environment, docker-based application, and R package for biomarker signature selection, feature selection, and deep-learning model development from high-throughput omics experiments and other multidimensional datasets; initially developed for miRNA-seq, RNA-seq, and qPCR.

  • seq-pipeline - workspace for data-science projects and NGS pipelines.

  • OmicApp - Shiny application framework integrating OmicSelector.

  • neurexam - interactive neurological examination assistant and electronic health record.

  • PancreApp - computational approach to individualizing nutritional therapy in chronic gastrointestinal disorders.

Certified courses

  • 2025: Clinical Scholars Research Training programme, Harvard Medical School / Polish Medical Research Agency, advanced clinical research training.
  • 2022: Single-cell RNA-seq data analysis workshop, Harvard Chan Bioinformatics Core (HBC), Boston, MA, USA
  • 2022: Bulk RNA-seq data analysis workshop (part 1 and 2), Harvard Chan Bioinformatics Core (HBC), Boston, MA, USA
  • 2016: “Computational Genomics” (Summer School), Max-Delbrück-Centre for Molecular Medicine, Berlin, Germany
  • 2016: “Fundamentals of Digital Image and Video Processing” (Coursera ID: ULTLWMZSCYEZ), Northwestern University , Evanston, IL, USA

Skills

  • Clinical oncology and radiotherapy: broad radiation-oncology practice with special focus on genitourinary and gastrointestinal cancers; prostate, bladder, and rectal cancer radiotherapy; brachytherapy, SBRT/SRS, radiochemotherapy, radioimmunotherapy, clinical-trial work, ward/team leadership, and practical AI implementation in clinical workflows.
  • Data science, biomarkers, and imaging: biostatistics, machine learning, data mining, radiomics, DICOM radiotherapy data, miRNA biomarkers, next-generation sequencing, bulk and single-cell RNA-seq, whole-exome sequencing, and clinical data workflows; tools include STATISTICA, MedCalc, IBM SPSS, Weka, 3D Slicer, ITK-SNAP, and pyRadiomics.
  • Software and product development: R/R Markdown/Shiny, OmicApp, reproducible pipelines, web products, research calculators, AI-assisted medical documentation, OCR, dictation, quality-control, evidence-update, and clinical-trial matching workflows.
  • Infrastructure and operations: Linux, Bash, Docker, Shiny Server, Apache/Nginx/PHP services, web deployment, SSH tunneling, firewalls, fail2ban, basic Windows Server, and security-minded server administration.
  • Programming: R (advanced; data processing, statistical analysis, applications, and data mining), Python (practical scripting and data workflows), C#/.NET (WinForms applications), and PHP (legacy/intermediate; WordPress, Bootstrap).

Organizational activity

  • 2024 - present: Editorial Board Member, BMC Cancer (Springer Nature).
  • 2023 - 2026: Elected member, ESTRO AI in RT Focus Group, an international working group on artificial intelligence in radiation oncology.
  • 2021 - present: Member of ESTRO (European Society for Radiotherapy and Oncology);
  • 2019 - present: Member of the Polish Oncological Society;
  • 2019 - present: Member of the Polish Society of Radiation Oncology;
  • 2017 - 2018: Member of the program council, Kuźnia Młodych Talentów, Academy of Young Scholars of the Polish Academy of Sciences.
  • 2014 - 2016: Individual Course of Studies at the Department of Biostatistics and Translational Medicine; tutor: Dr Wojciech Fendler;
  • 2013 - 2015: President of the Student Scientific Society of the Medical University of Lodz.
  • 2012 - 2013: Member of the Board of the Student Scientific Society of the Medical University of Lodz.
  • 2012 - 2013: Individual Course of Studies at the Department of Neurosurgery and Oncology of the Nervous System; tutor: Dr Krzysztof Tybor;
  • 2012 - 2015: Member of the Student Scientific Society at the Department of Neurosurgery;
  • 2011 - 2015: Member of the Student Research Group at the Faculty of Normal and Clinical Anatomy;
  • 2011 - 2015: International Association of Medical Students (IFMSA): (1) 2014: European Regional Meeting of Medicine Students, General Delegate of Poland, (2) 2013 - 2016: IFMSA New Technologies Support Division Director Assistant (international position), (3) 2013 - 2015: Member of the IFMSA-Poland marketing team (national position), (4) 2013 - 2015: IFMSA-Poland National New Technologies Director (national position), (5) 2012 - 2013: IFMSA-Poland National New Technologies Director Assistant (national position), (6) 2012 - 2013: Local coordinator of the project “Dying - a human thing” (local position), (7) 2011 - 2014: Local New Technologies Director (local position), (8) participation in 3 national IFMSA-Poland assemblies (Fall 2012, Spring 2012, Fall 2013).

This English CV was updated on 2026-07-08.

Jestem lekarzem specjalistą radioterapii onkologicznej i badaczem zajmującym się radioterapią kliniczną, data science w onkologii, biomarkerami molekularnymi, radiomiką i praktycznymi zastosowaniami AI w medycynie. Klinicznie zajmuję się szerokim zakresem radioterapii, ze szczególnym uwzględnieniem nowotworów układu moczowo-płciowego i przewodu pokarmowego.

Notatnik Medyczny Profil kliniczny Publikacje

Doświadczenie zawodowe

Profil kliniczny, badawczy i programistyczny

Szeroka praktyka radioterapeutyczna ze szczególnym uwzględnieniem nowotworów układu moczowo-płciowego i przewodu pokarmowego; radiomika i przetwarzanie danych radioterapeutycznych; biomarkery translacyjne; powtarzalne analizy onkologiczne; oraz narzędzia AI wspierające dokumentację medyczną.

PDF po polskuDOCX po polskuPDF po angielskuDOCX po angielskuKontakt

Produkty cyfrowe i narzędzia

Notatnik Medyczny

Platforma AI wspierająca ustrukturyzowaną dokumentację medyczną: dane od pacjenta przed wizytą, OCR, dyktowanie i kontrolę jakości. Publiczny prototyp hackathonowy jest dostępny jako Notatnik Medyczny (ADK Prototype).

Radioonkolog.pl

Profil kliniczny i strona informacyjna dla pacjentów konsultowanych z zakresu radioterapii.

Oprogramowanie badawcze

Otwarte narzędzia do potoków danych radioterapeutycznych, modelowania limfopenii popromiennej, priorytetyzacji wariantów, odkrywania biomarkerów i powtarzalnej analityki onkologicznej.

Działalność kliniczno-translacyjna

Od praktyki klinicznej do narzędzi i publikacji
Obszary specjalizacji

Wykształcenie

Staże i pobyty naukowe

Granty, projekty finansowane i innowacje

Nagrody, wyróżnienia i stypendia

Patenty i komercjalizacje

Badania i publikacje

H-index według Google Scholar: 19
(cytowania = 1095; prace/abstrakty = 97)

Pełne rekordy publikacji: PubMed, ORCID, OpenAlex, Google Scholar.

97rekordów Google Scholar
1 095cytowań Google Scholar
19H-index
2013-2026lata publikacji
Cytowania według roku
Rekordy publikacji według roku

Rekordy publikacji z Google Scholar

  • B Tomasik, M Jąkalski, M Bieńkowski, J Teodorczyk, BK Sobocki, … Non-invasive assessment of PD-L1 status and histology in non-small cell lung cancer using 18F-FDG PET/CT radiomics Journal of Translational Medicine 2026:24 (1), 587 [cytowania: 1]
  • JW Webber, L Wollborn, S Mishra, S Alimena, B Testino, K Stawiski, … A lasso-based model combining miRNA and clinical variables predicts future risk of breast and ovarian cancer Scientific Reports 2026: [cytowania: 0]
  • K Kuna, J Burzyński, D Mikulski, B Sobocki, A Papis-Ubych, K Stawiski, … Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy Contemporary Oncology/Współczesna Onkologia 2026:29 (1) [cytowania: 0]
  • M Golinska, A Rycerz, M Sobczak, J Chrzanowski, K Stawiski, W Fendler Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis Frontiers in Immunology 2025:16, 1619434 [cytowania: 12]
  • M Pajdziński, J Burzyński, A Zięba, N Jędrzejczak, J Fijuth, K Stawiski 4474 Risk of Neutropenia With or Without Daratumumab in Bortezomib-Based First-Line Chemotherapy and Radiotherapy for Multiple Myeloma: A Pilot Study Radiotherapy and Oncology 2025:206, S919-S920 [cytowania: 0]
  • K Stawiski, A der Rycerz, J Burzyński, K Kasper, W Fendler 4567 Radonek-Fine-Tuned GPT-4o for Radiation Oncology Patient Support: Preliminary Evaluation and Protocol for Prospective Validation Radiotherapy and Oncology 2025:206, S2417-S2418 [cytowania: 0]
  • MM Pietrzak, W Pietruszewska, M Barańska, A Rycerz, K Stawiski, … Assessment of the Interdependencies Between High-Speed Videoendoscopy and Simultaneously Recorded Audio Data in Various Glottal Pathologies Biomedicines 2025:13 (2), 511 [cytowania: 0]
  • D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microrna signatures for ovarian cancer US Patent 2025:12,385,099 [cytowania: 0]
  • D Chowdhury, W Fendler, K Stawiski Circulating microrna signatures for pancreatic cancer US Patent App. 2025:18/577,387 [cytowania: 0]
  • S Kołowacik, BJ Bińkowski, K Stawiski, J Drożdż Time efficiency and safety of antazoline in the rapid cardioversion of recent onset atrial fibrillation during supraventricular arrhythmias ablation Polish Heart Journal (Kardiologia Polska) 2025:83 (2), 203-206 [cytowania: 0]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, N Juanpere Rodero, J Lee, … Tumor B cell infiltration in platinum-treated advanced urothelial carcinoma bioRxiv 2025:2025.02. 27.640395 [cytowania: 0]
  • FLF Carvalho, J Lee, N Kalavros, Y Zhou, D Michaud, I Stelter, H Siddiqui, … Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer bioRxiv 2025:2025.09. 08.674862 [cytowania: 0]
  • Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Dose-volume metric-based prediction of radiotherapy-induced lymphocyte loss in patients with non-small-cell lung cancer treated with modern radiotherapy techniques Physics and Imaging in Radiation Oncology 2024:30, 100593 [cytowania: 12]
  • P Brady, A Yousif, N Sasamoto, AF Vitonis, W Fendler, K Stawiski, … Plasma microRNA expression in adolescents and young adults with endometriosis: the importance of hormone use Frontiers in Reproductive Health 2024:6, 1360417 [cytowania: 8]
  • A Puła, T Robak, I Dróżdż, K Stawiski, A Rycerz, M Misiewicz, P Robak Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens-pilot study Leukemia & Lymphoma 2024:65 (2), 257-264 [cytowania: 4]
  • Z Nowicka, K Kuna, M Łaszczych, K Stawiski, B Tomasik, W Fendler Effect of the time-of-day of radiotherapy administration on radiation-induced lymphocyte depletion in lung cancer International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e52 [cytowania: 3]
  • K Stawiski, RT Fortner, L Pestarino, SU Umu, R Kaaks, TB Rounge, … Validation of miRNA signatures for ovarian cancer earlier detection in the pre-diagnosis setting using machine learning approaches Frontiers in oncology 2024:14, 1389066 [cytowania: 3]
  • Z Nowicka, K Kuna, K Stawiski, J Sołek, M Świderek, A Papis-Ubych, … Extreme acute radiation-induced toxicity in a patient with polymorphous low-grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes Head & Neck 2024:46 (2), E10-E17 [cytowania: 1]
  • D Mikulski, M Nowicki, I Dróżdż, E Perdas, P Strzałka, K Kościelny, … MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation Biomarker Research 2024:12 (1), 42 [cytowania: 1]
  • K Stawiski, M Bilski, J Nowak-Potemska, M Bilewicz, J Fijuth Radiation induced lymphopenia depends on lymph node irradiation in prostate cancer radiotherapy International Journal of Radiation Oncology, Biology, Physics 2024:120 (2), e549-e550 [cytowania: 1]
  • JW Webber, L Wollborn, S Mishra, AF Vitonis, DW Cramer, RT Phan, … Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass Gynecologic Oncology 2024:190, 124-130 [cytowania: 1]
  • M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth 1994: Predicting neutropenia dynamics after RT in first-line Bortezomib-based chemo for MM-a pilot study Radiotherapy and Oncology 2024:194, S1165-S1168 [cytowania: 0]
  • K Stawiski, M Pajdziński, A Zięba, M Masłowski, J Fijuth 3178: Development of a CT-only autosegmentation model for hippocampal delineation in radiation therapy. Radiotherapy and Oncology 2024:194, S3165-S3166 [cytowania: 0]
  • CJ Magnani, VD DAndrea, K Stawiski, I Stelter, T Hanlon, L Jia, AS Kibel, … AIRD1A knockouts in bladder cancer cell lines leads to MYC and E2F activation implicated in more aggressive tumor behavior European Urology 2024:85, S219-S220 [cytowania: 0]
  • F Mohammed, K Stawiski, HS Musa, SK Owolabi, S Abubakar, SO Rotimi, … Co-expression of HERV-R, CCND1, BRAF, FOXA1, TMPRSS2, ATF4 and low expression of BAZ1B and KMT2D is associated with early detection and poor prognosis of prostate cancer in … Cancer Research 2024:84 (6_Supplement), 6432-6432 [cytowania: 0]
  • Z Nowicka, K Kuna, M Łaszczych, M Łazar-Poniatowska, BK Sobocki, … Physics and Imaging in Radiation Oncology Oncology 2024:30 [cytowania: 0]
  • BA Łochowska, K Stawiski, K Kuna, Z Nowicka, M Łochowski, J Fijuth Predicting overall survival in non-small cell lung cancer patients receiving concurrent radiochemotherapy and adjuvant durvalumab-a Polish real-world single-center experience Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2024:9 (3), 190-196 [cytowania: 0]
  • A Suleja, M Bliski, E Laukhtina, P Rajwa, K Stawiski, M Miszczyk Radioterapia stereotaktyczna (SBRT) w leczeniu pierwotnie zlokalizowanego raka nerkowokomórkowego (RCC)-przegląd systematyczny i metaanaliza Biuletyn Polskiego Towarzystwa Onkologicznego NOWOTWORY 2024:9 (Suppl. 1) [cytowania: 0]
  • FLF De Carvalho, J Lee, K Bi, B Titchen, K Stawiski, J Park, A Garza, … Tumor-immune interactions and cisplatin resistance in localized muscle-invasive bladder cancer Cancer Research 2024:84 (6_Supplement), 7041-7041 [cytowania: 0]
  • M Miszczyk, Ł Magrowski, T Krzysztofiak, R Stando, W Majewski, … Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group … Radiotherapy and Oncology 2023:183, 109632 [cytowania: 29]
  • Y Zhou, J Börcsök, E Adib, SC Kamran, AJ Neil, K Stawiski, D Freeman, … ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer Science advances 2023:9 (47), eadg2263 [cytowania: 25]
  • K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles Nature communications 2023:14 (1), 3350 [cytowania: 20]
  • Z Nowicka, B Tomasik, D Kozono, K Stawiski, T Johnson, D Haas-Kogan, … Serum miRNA-based signature indicates radiation exposure and dose in humans: a multicenter diagnostic biomarker study Radiotherapy and Oncology 2023:185, 109731 [cytowania: 12]
  • J Malinowski, W Pietruszewska, K Stawiski, MM Pietrzak, M Barańska, … High-speed videoendoscopy enhances the objective assessment of glottic organic lesions: a case-control study with multivariable data-mining model development Cancers 2023:15 (14), 3716 [cytowania: 5]
  • M Masłowski, K Stawiski, A Zięba, D Mikulski, J Bednarek, J Fijuth Predicting neutropenia dynamics after radiation therapy in multiple myeloma patients receiving first-line bortezomib-based chemotherapy-a pilot study Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2023:8 (4), 274-283 [cytowania: 1]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, NJ Rodero, KW Mouw, … Assessing tumor-infiltrating immune cells and outcomes with cisplatin-versus carboplatin-based treatment in advanced urothelial cancer (UC): Survival analysis of three platinum … Journal of Clinical Oncology 2023:41 (16_suppl), 4583-4583 [cytowania: 0]
  • M Jobczyk, K Stawiski, M Kaszkowiak, P Rajwa, W Różański, F Soria, … Deep learning-based recalibration of the CUETO and EORTC prediction tools for recurrence and progression of non-muscle-invasive bladder cancer European urology oncology 2022:5 (1), 109-112 [cytowania: 37]
  • K Mieczkowski, K Kitowska, M Braun, B Galikowska-Bogut, … FGF7/FGFR2-JunB signalling counteracts the effect of progesterone in luminal breast cancer Molecular Oncology 2022:16 (15), 2823-2842 [cytowania: 22]
  • Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski, M Ciążyńska, … The kinetics of FMS-related tyrosine kinase 3 ligand (Flt-3L) during chemoradiotherapy suggests a potential gain from the earlier initiation of immunotherapy Cancers 2022:14 (16), 3844 [cytowania: 17]
  • M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFbeta gene polymorphism in asthma: TGF-related SNP analysis enhances the prediction of disease diagnosis (a case-control study with multivariable data-mining model … Frontiers in immunology 2022:13, 746360 [cytowania: 14]
  • K Stawiski, M Kaszkowiak, D Mikulski, P Hogendorf, A Durczyński, … OmicSelector: automatic feature selection and deep learning modeling for omic experiments BioRxiv 2022:2022.06. 01.494299 [cytowania: 12]
  • W Fendler, B Tomasik, K Atkins, K Stawiski, J Chałubińska-Fendler, … The clinician’s guide to radiotherapy complications Polskie Archiwum Medycyny Wewnętrznej 2022:132 (1) [cytowania: 10]
  • A Gockley, K Pagacz, S Fiascone, K Stawiski, N Holub, K Hasselblatt, … A translational model to improve early detection of epithelial ovarian cancers Frontiers in Oncology 2022:12, 786154 [cytowania: 8]
  • M Miszczyk, J Rembak-Szynkiewicz, Ł Magrowski, K Stawiski, … The prognostic value of PI-RADS score in CyberKnife ultra-hypofractionated radiotherapy for localized prostate cancer Cancers 2022:14 (7), 1613 [cytowania: 8]
  • EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma amino acids may improve prediction accuracy of cerebral vasospasm after aneurysmal subarachnoid haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [cytowania: 6]
  • S Kubik, D Jesionek-Kupnicka, K Stawiski, J Fijuth, … Clinical significance of CD34, podoplanin and Ki-67 expression in patients with locally advanced squamous cell cervical carcinoma Journal of Obstetrics and Gynaecology 2022:42 (6), 2248-2254 [cytowania: 5]
  • EJ Bobeff, K Stawiski, PA Stanisławska, BJ Posmyk, K Wiśniewski, M Bryl, … Validation of the elderly traumatic brain injury score: observational case control study World neurosurgery 2022:161, e464-e472 [cytowania: 5]
  • D Chowdhury, KM Elias, W Fendler, K Stawiski Circulating microRNA signatures for ovarian cancer US Patent 2022:11,214,839 [cytowania: 3]
  • K Stawiski, M Maslowski, W Maslowska, M Kordzinska, B Lochowska, … Clinical and Radiomics-Based Deep Learning Predictive Model for Early Treatment Failure after Neoadjuvant Radiochemotherapy for Rectal Cancer International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e150 [cytowania: 0]
  • M Panek, K Stawiski, M Kaszkowiak, P Kuna Cytokine TGFbeta gene polymorphisms in asthma Frontiers in Immunology 2022:13 [cytowania: 0]
  • A Napieralska, J Bochenek-Cibor, A Chyrek, M Konkol, E Pawłowska, … Improving Education in Radiation Oncology in Poland International Journal of Radiation Oncology, Biology, Physics 2022:114 (1), e4-e5 [cytowania: 0]
  • EJ Bobeff, M Bukowiecka-Matusiak, K Stawiski, K Wiśniewski, … Plasma Amino Acids May Improve Prediction Accuracy of Cerebral Vasospasm after Aneurysmal Subarachnoid Haemorrhage Journal of Clinical Medicine 2022:11 (2), 380 [cytowania: 0]
  • D Mikulski, M Nowicki, I Dróźdż, E Perdas, P Strzałka, K Kościelny, … Serum miRNA-based neural network models for predicting complications in patients receiving high-dose melphalan or BeEAM conditioning chemotherapy. Acta Haematologica Polonica 2022:53 [cytowania: 0]
  • M Miszczyk, J Ciepał, R Stando, O Masri, I Jabłońska, K Stawiski, … The Association between Dose Escalation and Risk of Developing Metastases in Intermediate and High-Risk Prostate Cancer Patients Treated with Radiotherapy International Journal of Radiation Oncology, Biology, Physics 2022:114 (3), e231 [cytowania: 0]
  • M Miszczyk, E Staniewska, I Jabłońska, A Lipka-Rajwa, K Stawiski, … Volumetric staging in radiotherapy for oropharyngeal cancers Tumori Journal 2022:108 (6), 586-591 [cytowania: 0]
  • P Robak, D Jarych, D Mikulski, I Dróżdż, E Węgłowska, A Kotkowska, … The prognostic value of whole-blood PSMB5, CXCR4, POMP, and RPL5 mRNA expression in patients with multiple myeloma treated with bortezomib Cancers 2021:13 (5), 951 [cytowania: 23]
  • B Tomasik, A Papis-Ubych, K Stawiski, J Fijuth, P Kędzierawski, … Serum microRNAs as xerostomia biomarkers in patients with oropharyngeal cancer undergoing radiation therapy International Journal of Radiation Oncology Biology* Physics 2021:111 (5), 1237-1249* [cytowania: 18]
  • P Michał, S Konrad, K Piotr TGF-beta gene polimorphisms as risk factors for asthma control among clinic patients Journal of Inflammation 2021:18 (1), 28 [cytowania: 13]
  • L Lee, B Howitt, T Cheng, M King, K Stawiski, W Fendler, D Chowdhury, … MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma Gynecologic oncology 2021:163 (3), 453-458 [cytowania: 9]
  • D Mikulski, I Dróżdż, E Perdas, K Stawiski, M Nowicki, M Misiewicz, … Changes in the microrna expression profile in patients undergoing autologous steam cell transplantation Blood 2021:138, 4789 [cytowania: 5]
  • M Miszczyk, W Majewski, K Stawiski, K Rasławski, P Rajwa, I Jabłońska, … Prognostic factors in postoperative radiotherapy for prostate cancer-tertiary center experience Radiology and Oncology 2021:55 (2), 203 [cytowania: 4]
  • Z Nowicka, R Bibik, R Stando, W Fendler, K Stawiski, B Tomasik A link between seasonality and radiation-related toxicity: The big time or time will tell? Radiotherapy and Oncology 2021:161, 257-258 [cytowania: 2]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … Correction to: A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence BMC genomics 2021:22 (1), 327-327 [cytowania: 1]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence (vol 19, 37 … BMC GENOMICS 2021:22 (1) [cytowania: 0]
  • B Małachowska, B Tomasik, K Stawiski, S Kulkarni, C Guha, … Circulating microRNAs as biomarkers of radiation exposure: a systematic review and meta-analysis International Journal of Radiation Oncology Biology* Physics 2020:106 (2), 390-402* [cytowania: 64]
  • M Jobczyk, K Stawiski, W Fendler, W Różański Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC … Cancer Medicine 2020:9 (11), 4014-4025 [cytowania: 59]
  • P Robak, I Dróżdż, D Jarych, D Mikulski, E Węgłowska, M Siemieniuk-Ryś, … The value of serum microRNA expression signature in predicting refractoriness to bortezomib-based therapy in multiple myeloma patients Cancers 2020:12 (9), 2569 [cytowania: 28]
  • Ł Kuncman, K Stawiski, M Masłowski, J Kucharz, J Fijuth Dose-volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer Strahlentherapie und Onkologie 2020:196 (11), 998-1005 [cytowania: 27]
  • M Braun, D Piasecka, B Tomasik, K Mieczkowski, K Stawiski, A Zielinska, … Hormonal receptor status determines prognostic significance of FGFR2 in invasive breast carcinoma Cancers 2020:12 (9), 2713 [cytowania: 17]
  • Z Nowicka, B Tomasik, DE Kozono, K Stawiski, TJ Johnson, … Serum Circulating MicroRNAs as Functional Biodosimeters in Patients Undergoing Total Body Irradiation International Journal of Radiation Oncology, Biology, Physics 2020:108 (3), e536 [cytowania: 0]
  • Z Nowicka, K Stawiski, B Tomasik, W Fendler Extracellular miRNAs as biomarkers of head and neck cancer progression and metastasis International journal of molecular sciences 2019:20 (19), 4799 [cytowania: 45]
  • A Zmyslowska, A Waszczykowska, D Baranska, K Stawiski, M Borowiec, … Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome Developmental Medicine & Child Neurology 2019:61 (3), 359-365 [cytowania: 27]
  • EJ Bobeff, J Fortuniak, B Bryszewski, K Wiśniewski, M Bryl, K Kwiecień, … Mortality after traumatic brain injury in elderly patients: a new scoring system World neurosurgery 2019:128, e129-e147 [cytowania: 26]
  • M Kotlicka-Antczak, MS Karbownik, K Stawiski, A Pawełczyk, N Żurner, … Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state European Psychiatry 2019:58, 72-79 [cytowania: 26]
  • M Zakrzewska, R Gruszka, K Stawiski, W Fendler, J Kordacka, … Expression-based decision tree model reveals distinct microRNA expression pattern in pediatric neuronal and mixed neuronal-glial tumors BMC cancer 2019:19 (1), 544 [cytowania: 17]
  • EJ Bobeff, BJ Posmyk, K Bobeff, J Fortuniak, K Wiśniewski, K Stawiski, … Predicting outcome and conservative treatment failure in patients with skull fracture after traumatic brain injury: a retrospective cohort study Journal of Neurological Surgery Part A: Central European Neurosurgery 2019:80 (06 … [cytowania: 5]
  • L Kuncman, K Stawiski, M Maslowski, J Wilczynska, J Bury, J Fijuth FT3-L Dynamics in Blood Could be Predictive of Time of Occurrence Lymphocyte Nadir in Patients Undergoing Preoperative Chemoradiotherapy for Rectal Cancer. International Journal of Radiation Oncology, Biology, Physics 2019:105 (1), E167-E168 [cytowania: 0]
  • ES Komseli, IS Pateras, T Krejsgaard, K Stawiski, SV Rizou, A Polyzos, … A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced … BMC genomics 2018:19 (1), 37 [cytowania: 61]
  • K Pagacz, K Stawiski, A Szadkowska, W Mlynarski, W Fendler GlyCulator2: an update on a web application for calculation of glycemic variability indices Acta diabetologica 2018:55 (8), 877-880 [cytowania: 37]
  • A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized … Leukemia & Lymphoma 2018:59 (5), 1084-1094 [cytowania: 24]
  • K Stawiski, I Pietrzak, W Młynarski, W Fendler, A Szadkowska NIRCa: An artificial neural network-based insulin resistance calculator Pediatric Diabetes 2018:19 (2), 231-235 [cytowania: 15]
  • KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer elife 2017:6, e28932 [cytowania: 174]
  • J Trelinska, I Dachowska, D Baranska, K Stawiski, K Kotulska, W Fendler, … Maintenance therapy with everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis (the EMINENTS study) Pediatric blood & cancer 2017:64 (6), e26347 [cytowania: 37]
  • K Stawiski, J Trelińska, D Baranska, I Dachowska, K Kotulska, S Jóźwiak, … What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods Magnetic Resonance Materials in Physics, Biology and Medicine 2017:30 (4), 397-405 [cytowania: 9]
  • KM Elias, W Fendler, K Stawiski, SJ Fiascone, AF Vitonis, RS Berkowitz, … Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer. Elife eLife Sciences Publications Limited 2017:6, e28932 [cytowania: 6]
  • A Pula, K Stawiski, M Braun, E Iskierka-Jazdzewska, T Robak A systematic review and meta-analysis of B-cell receptor signaling inhibitors in relapsed and refractory chronic lymphocytic leukemia LEUKEMIA & LYMPHOMA 2017:58, 152-153 [cytowania: 0]
  • A Puła, KG Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Bezpieczeństwo i efektywność kliniczna nowych inhibitorów szlaku sygnałowego receptorów limfocytów B w leczeniu nawrotowej i opornej przewlekłej białaczki limfocytowej … Acta Haematologica Polonica 2017:48 (Supl. 1) [cytowania: 0]
  • M Zakrzewska, W Fendler, K Stawiski, R Gruszka, K Zakrzewski, … Comparative Analysis of miRNA Expression in Pediatric Neuronal and Mixed Neuronal-Glial Tumors PEDIATRIC BLOOD & CANCER 2017:64, S318-S318 [cytowania: 0]
  • LJ Lee, BE Howitt, W Fendler, K Stawiski, P Bu, L Cho, D Chowdhury, … miRNA profiling in a case: Control study of African American women with uterine serous carcinoma (USC). Journal of Clinical Oncology 2017:35 (15_suppl), e17116-e17116 [cytowania: 0]
  • KM Elias, WF Fendler, K Stawiski, A Vitonis, RS Berkowitz, DW Cramer, … Serum MicroRNA Sequencing for Early Diagnosis of Invasive Ovarian Cancer. REPRODUCTIVE SCIENCES 2017:24, 87A-87A [cytowania: 0]
  • Ł Dziki, A Puła, K Stawiski, B Mudza, M Włodarczyk, A Dziki Patients’ awareness of the prevention and treatment of colorectal cancer Polish Journal of Surgery 2015:87, 459-463 [cytowania: 16]
  • K Stawiski, A Strzałka, A Puła, K Bijakowski PancreApp: an innovative approach to computational individualization of nutritional therapy in chronic gastrointestinal disorders MEDINFO 2015:2015: eHealth-enabled Health, 325-328 [cytowania: 10]
  • A Strzałka, K Stawiski, A Kaczmarek, A Kuchareczko, M Polguj, M Topol Analiza zmienności morfologicznych i topograficznych w zakresie struktur nerwowych i mięśniowych jamy pachowej (axillary fossa) w kontekście ich ewentualnych implikacji klinicznych Wydawnictwo Uniwersytetu Medycznego w Gdańsku 2013: [cytowania: 0]
  • Ł Kuncman, M Orzechowska, K Stawiski, M Masłowski Ciazy nska, M Gottwald, L n.d.: [cytowania: 4]
  • K Elias, U Smyczynska, K Stawiski, Z Nowicka, J Webber, J Kaplan, … Identification of BRCA1/2 mutation female carriers using circulating microRNA pro les screening n.d.:10, 1 [cytowania: 0]
  • K Stawiski, Ł Kuncman, M Jobczyk, M Bilski, C Franzese, M Orzechowska, … Pre-Treatment Sacral Bone Geometry Predicts Radiation-Induced Lymphopenia in Prostate Cancer Available at SSRN n.d.:650635 [cytowania: 0]
  • K Stawiski, J Perera-Bel, A Rodriguez-Vida, N Juanpere, J Lee, … Tumor B-cell infiltration in platinum-treated advanced muscle-invasive urothelial carcinoma Molecular Oncology n.d.: [cytowania: 0]

Rozdziały w książkach

  • Konrad Stawiski, Łukasz Polak, Wojciech Fendler, Jarosław Drożdż. Evidence-based medicine w kardiologii. WIELKA INTERNA: Kardiologia część 1 - wydanie II. Medical Tribune Polska 2018.
  • Konrad Stawiski, Jacek Fijuth. Sztuczna inteligencja w onkologii. Innowacyjna Onkologia: potrzeby, możliwości, system. PZWL 2020. ISBN 978-83-200-6032-4.

Dydaktyka i wykłady zaproszone

  • 2025: “Jak sztuczna inteligencja może wpłynąć na zwiększenie możliwości realizacji radioterapii - praktyka i perspektywa?”, XI Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź. Program
  • 2025: “Radioterapia w miejscowo zaawansowanym raku odbytnicy - należy eskalować leczenie systemowe”, Konferencja 4R “Dokąd zmierza nowoczesna radioterapia - Eskalacja czy Deeskalacja?”. Program
  • 2025: “Optymalizacja radio-chemioterapii po przezcewkowej resekcji (TMT) w raku pęcherza moczowego w świetle aktualnych badań”, “MISSION POSSIBLE” - Precyzja i personalizacja w onkologii, CMEducation, Warszawa. Program
  • 2025: “Leczenie trójmodalne vs cystectomia z leczeniem okołooperacyjnym - dla kogo co jest optymalnym wyborem?” - perspektywa radioterapeuty, Uro-Onko Expert Meeting, CMEducation, Łódź. Program
  • 2024: “Total Neoadjuvant Treatment w raku odbytnicy - czy jest już standardem? Kiedy eskalować, kiedy deeskalować intensywność leczenia?”, VIII Konferencja 4R - Radioterapeuci Radioterapeutom, Warszawa. Program
  • 2024: “Synergia leczenia celowanego i radioterapii w badaniach klinicznych”, Precyzja i personalizacja - “MISSION POSSIBLE” w onkologii, CMEducation, Warszawa. Program
  • 2024: “Pisanie prac naukowych w dobie AI”, wykład i materiały edukacyjne dla Young PTRO. Slajdy
  • 2023: “Odmienne twarze Greja - dawki biologicznie równoważne w zależności od sposobu frakcjonowania i lokalizacji anatomicznej”, konferencja “Radioterapia stereotaktyczna w dobie leczenia celowanego”, Warszawa. Program archiwalny
  • 2023: “Wyniki badania klinicznego - analiza oraz ocena wartości”, studia podyplomowe “Non-commercial Clinical Research - Design, Implementation and Management”, Uniwersytet Medyczny we Wrocławiu.
  • 2022: “Czy sztuczna inteligencja zastąpi człowieka w planowaniu leczenia promieniami?”, X Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź.
  • 2022: “Deep artificial neural networks in the integration of the expression profile of circulating and intracellular miRNA molecules in pancreatic cancer patients”, Łódzkie Dni Onkologiczne, Łódź.
  • 2022: “Time series analysis”, studia podyplomowe “Elements of empirical research methodology in medicine and application of statistics in biomedical research”, Uniwersytet Medyczny w Łodzi.
  • 2022: “Introduction to Data Mining methods and the STATISTICA Data Miner system”, studia podyplomowe “Elements of empirical research methodology in medicine and application of statistics in biomedical research”, Uniwersytet Medyczny w Łodzi.
  • 2021 - 2022: “Data in clinical trials (CRF) and database management”, studia podyplomowe “Non-commercial Clinical Research - Design, Implementation and Management”, Uniwersytet Medyczny we Wrocławiu.
  • 2021 - 2022: “New Technologies in Clinical Trials. Big Data”, studia podyplomowe “Non-commercial Clinical Research - Design, Implementation and Management”, Uniwersytet Medyczny we Wrocławiu.
  • 2021: “Zastosowanie zaawansowanych narzędzi statystycznych i sztucznej inteligencji w prognozowaniu rokowania i odpowiedzi na leczenie w raku gruczołu krokowego”, “Rak stercza - wielodyscyplinarne podejście do terapii po niepowodzeniu leczenia miejscowego i w chorobie z przerzutami”, webinar 90C. Program
  • 2021: “Testy diagnostyczne, modele predykcyjne (regresja logistyczna)”, warsztaty naukowo-biostatystyczne youngPTRO, Sekcja Młodych Polskiego Towarzystwa Radioterapii Onkologicznej. Nagranie
  • 2019: “Kobiety w nauce”, Pałacowy Salon Naukowy, Akademia Młodych Uczonych PAN, Jabłonna, z Beatą Małachowską. Strona wydarzenia
  • 2019: “Nauczanie głębokie jako technika zwiększania skuteczności biomarkerów molekularnych”, IX Zjazd Polskiego Towarzystwa Radioterapii Onkologicznej, Łódź. Program archiwalny
  • 2018: “Data mining to discover ovarian cancer signature in the miRNA serum profile”, Elias Lab Meeting, Brigham and Women’s Hospital / Dana-Farber Cancer Institute, Boston, MA, USA.
  • 2018: “From anatomy to artificial intelligence in oncology”, lokalna konferencja popularyzująca naukę.

Badania kliniczne komercyjne

  • TALAPRO-2 (B9991040 / NCT04052204): badanie III fazy talazoparybu z enzalutamidem w przerzutowym opornym na kastrację raku prostaty.
  • NC-6004-009 (NCT03771820): badanie Ib/II fazy NC-6004, nanocząsteczkowej formulacji cisplatyny, z pembrolizumabem w zaawansowanych guzach litych.
  • KEYNOTE-867 (MK-3475-867 / NCT03924869): badanie III fazy pembrolizumabu z jednoczasową radiochemioterapią w miejscowo zaawansowanym niedrobnokomórkowym raku płuca.
  • KEYNOTE-689 (MK-3475-689 / NCT03765918): badanie III fazy pembrolizumabu w leczeniu neoadjuwantowym i adjuwantowym resekcyjnego miejscowo zaawansowanego raka płaskonabłonkowego głowy i szyi.
  • CALLA (D910SC00001 / NCT04550260): badanie III fazy durwalumabu z radiochemioterapią w miejscowo zaawansowanym raku szyjki macicy.

Oprogramowanie badawcze i narzędzia

  • rect-ril (Zenodo DOI: 10.5281/zenodo.19595346) - potok analityczny R/Python i interaktywny kalkulator ryzyka ciężkiej limfopenii popromiennej w raku odbytnicy.
  • Notatnik Medyczny (ADK Prototype) - publiczny prototyp hackathonowy pokazujący wybrane funkcje wspierające tworzenie dokumentacji medycznej w Notatniku Medycznym.
  • RTpipeline - potok badawczy przekształcający surowe eksporty DICOM radioterapii w dane gotowe do analiz radioterapeutycznych, radiomicznych, DVH i uczenia maszynowego (dokumentacja).
  • Somatic Likelihood Tiering - interpretowalny, wieloźródłowy system priorytetyzacji wariantów w sekwencjonowaniu whole-exome tumor-only. Zenodo DOI: 10.5281/zenodo.19572621
  • Prostate AS-counselling calculators - otwarty kalkulator wspierający konsultację w aktywnym nadzorze raka prostaty, szacujący ryzyko podwyższenia grupy ISUP między biopsją a prostatektomią (Jobczyk et al. 2026).
  • OmicSelector - środowisko, aplikacja dockerowa i pakiet R do selekcji cech, budowy sygnatur biomarkerowych i modeli deep learning dla eksperymentów omicznych oraz danych wielowymiarowych; rozwijany początkowo dla miRNA-seq, RNA-seq i qPCR.
  • seq-pipeline - repozytorium i potok analityczny dla projektów data science oraz analiz NGS.
  • OmicApp - framework aplikacji Shiny z integracją OmicSelector.
  • neurexam - interaktywny asystent badania neurologicznego i elektroniczna dokumentacja badania.
  • PancreApp - podejście informatyczne do indywidualizacji terapii żywieniowej w przewlekłych chorobach przewodu pokarmowego.

Kursy certyfikowane

  • 2025: Clinical Scholars Research Training programme, Harvard Medical School / Agencja Badań Medycznych, zaawansowane szkolenie z badań klinicznych.
  • 2022: warsztaty z analizy danych single-cell RNA-seq, Harvard Chan Bioinformatics Core, Boston, MA, USA.
  • 2022: warsztaty z analizy danych bulk RNA-seq, Harvard Chan Bioinformatics Core, Boston, MA, USA.
  • 2016: “Computational Genomics”, Max-Delbrück-Centre for Molecular Medicine, Berlin, Germany.
  • 2016: “Fundamentals of Digital Image and Video Processing”, Northwestern University, Evanston, IL, USA.

Kompetencje

  • Klinika i radioterapia: szeroka praktyka w radioterapii onkologicznej ze szczególnym naciskiem na nowotwory układu moczowo-płciowego i przewodu pokarmowego; radioterapia raka prostaty, pęcherza i odbytnicy; brachyterapia, SBRT/SRS, radiochemioterapia, radioimmunoterapia, badania kliniczne, zarządzanie zespołem i wdrażanie AI w przepływach klinicznych.
  • Data science, biomarkery i obrazowanie: biostatystyka, machine learning, data mining, radiomika, dane DICOM RT, biomarkery miRNA, NGS, bulk/sc RNA-seq, WXS, STATISTICA, MedCalc, IBM SPSS, Weka, 3D Slicer, ITK SNAP, pyRadiomics i kliniczne przepływy danych.
  • Oprogramowanie i produkty: R/R Markdown/Shiny, OmicApp, powtarzalne potoki analityczne, produkty webowe, kalkulatory badawcze, dokumentacja medyczna wspierana przez AI, OCR, dyktowanie, kontrola jakości, aktualizacje wiedzy i dopasowywanie badań klinicznych.
  • Infrastruktura: Linux, Bash, Docker, Shiny Server, Apache/Nginx/PHP, wdrożenia webowe, SSH tunneling, firewalle, fail2ban, podstawy Windows Server i administracja serwerami z uwzględnieniem bezpieczeństwa.
  • Programowanie: R (zaawansowany; przetwarzanie danych, analiza statystyczna, aplikacje i data mining), Python (praktyczne skrypty i przepływy danych), C#/.NET (aplikacje WinForms) oraz PHP (legacy/intermediate, WordPress, Bootstrap).

Działalność organizacyjna

  • 2024 - obecnie: Editorial Board Member, BMC Cancer.
  • 2023 - 2026: wybrany członek ESTRO AI in RT Focus Group.
  • 2021 - obecnie: członek ESTRO.
  • 2019 - obecnie: członek Polskiego Towarzystwa Onkologicznego i Polskiego Towarzystwa Radioterapii Onkologicznej.
  • 2017 - 2018: członek rady programowej Kuźni Młodych Talentów, Akademia Młodych Uczonych Polskiej Akademii Nauk.
  • 2014 - 2016: indywidualny tok studiów w Zakładzie Biostatystyki i Medycyny Translacyjnej; opiekun: dr Wojciech Fendler.
  • 2013 - 2015: przewodniczący Studenckiego Towarzystwa Naukowego Uniwersytetu Medycznego w Łodzi.
  • 2012 - 2013: członek Zarządu Studenckiego Towarzystwa Naukowego Uniwersytetu Medycznego w Łodzi.
  • 2012 - 2013: indywidualny tok studiów w Klinice Neurochirurgii i Onkologii Układu Nerwowego; opiekun: dr Krzysztof Tybor.
  • 2012 - 2015: członek Studenckiego Koła Naukowego przy Klinice Neurochirurgii.
  • 2011 - 2015: członek Studenckiego Koła Naukowego przy Zakładzie Anatomii Prawidłowej i Klinicznej.
  • 2011 - 2015: aktywność w IFMSA i IFMSA-Poland: (1) 2014: European Regional Meeting of Medical Students, General Delegate of Poland; (2) 2013 - 2016: IFMSA New Technologies Support Division Director Assistant, funkcja międzynarodowa; (3) 2013 - 2015: członek zespołu marketingowego IFMSA-Poland; (4) 2013 - 2015: IFMSA-Poland National New Technologies Director; (5) 2012 - 2013: IFMSA-Poland National New Technologies Director Assistant; (6) 2012 - 2013: lokalny koordynator projektu “Umieranie - ludzka rzecz”; (7) 2011 - 2014: Local New Technologies Director; (8) udział w trzech zgromadzeniach krajowych IFMSA-Poland.

Polska wersja CV została zaktualizowana 2026-07-08.

Copyright © 2026 Konrad Stawiski (konrad@konsta.com.pl). Built as OmicApp by Konrad Stawiski.